Covington Represents OrbiMed in $50M Financing
May 04, 2024
May 04, 2024
NEW YORK, May 4 -- Covington, a law firm, issued the following news release:
Covington advised OrbiMed Advisors, LLC, a healthcare investment firm, in a debt financing facility for up to $50 million with TriSalus Life Sciences Inc. Under the terms of the agreement, TriSalus borrowed $25 million at the closing of the transaction. Additionally, if certain specified revenue thresholds are achieved, TriSalus will be able to borrow an aggregate of an additional $25 million available in t . . .
Covington advised OrbiMed Advisors, LLC, a healthcare investment firm, in a debt financing facility for up to $50 million with TriSalus Life Sciences Inc. Under the terms of the agreement, TriSalus borrowed $25 million at the closing of the transaction. Additionally, if certain specified revenue thresholds are achieved, TriSalus will be able to borrow an aggregate of an additional $25 million available in t . . .